![]() ![]() Actual counts may exceed population estimates and lead to >100% coverage, especially in small race-ethnicity subgroups of each age group. Updated, bivalent doses became available in Fall 2022 and were created with the original strain of COVID-19 and newer Omicron variant strains.Ĭoverage estimates by age and race-ethnicity are capped at 99%. Updated (bivalent) booster dose: People who have received a n updated (bivalent) COVID-19 vaccine dose.Monovalent vaccines are the first vaccines that were created from the original strain of the virus that causes COVID-19. This includes booster doses and additional doses for people who are immunocompromised. Original booster/additional dose: People who have received another dose of a monovalent COVID-19 vaccine after being completing their primary series.Completed primary series: People who have completed a primary series of COVID-19 vaccination.At least one dose: People who received at least one dose of a COVID-19 vaccine (includes people that have received > 1 dose of vaccine).More detailed descriptions of the data and downloadable files are available on the Chicago Data Portal. Inconsistencies in records of separate doses administered to the same person, such as slight variations in dates of birth, can result in duplicate first dose records for a person and overestimate of the number of people with at least one dose and underestimate the number of people with a completed primary series or booster dose. Due to people receiving vaccinations that are not recorded in I-CARE and linked to their record, such as someone receiving a vaccine dose in another state, the number of people with a completed primary series or a booster dose is underestimated. The Chicago Department of Public Health uses the most complete data available to estimate COVID-19 vaccination coverage among Chicagoans, but there are several limitations that impact our estimates. The Veterans Health Administration began reporting doses in I-CARE beginning September 2022. Doses administered by the federal Bureau of Prisons and Department of Defense are not currently reported in I-CARE. I-CARE includes doses administered in Illinois and some doses administered outside of Illinois and reported in I-CARE by Illinois providers. This may include people who completed the primary series outside of NYC and received a bivalent dose in NYC.Vaccine data come from the Illinois Comprehensive Automated Immunization Registry Exchange (ICARE). Bivalent Dose: People who have received a bivalent dose of vaccine.This includes first and second monovalent booster doses, as well as additional doses for people who are immunocompromised. Monovalent Additional Dose/Booster: People who have received additional doses of an FDA-approved or authorized monovalent vaccine after completing their primary series.Completed Primary Series: People who have received the two-dose series of the Moderna, Pfizer, Novavax vaccine or the single-dose series of the Johnson & Johnson vaccine. ![]() The data below show how vaccinations in NYC have progressed since December 2020.ĭata on this page come from the Citywide Immunization Registry (CIR). Including the demographics and locations of people who have received the vaccine. The Health Department is closely monitoring the status of vaccinations in NYC, The COVID-19 vaccine is now available to all New York residents 6 months and older. Bivalent vaccine data for those under 5 will be updated once data become available. Data on bivalent vaccines represent doses given to NYC residents ages 5 and older. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |